date,title,stock,close,volume,1_past_close,2_past_close,3_past_close,4_past_close,5_past_close,next_close,next_volume,label
2010-07-21,A Peek Into The Market Before The Trading Starts,RHHBY,-0.0242422376527842,0.5480754716981131,-0.0350876688618511,-0.008120549508634,-0.04672385793534,0.0174402671165543,0.0016904339871928,0.0248445245205826,-0.5683989859594384,0
2011-05-17,Merck and Roche Establish Strategic Agreements in Fight Against Chronic Hepatitis C ,RHHBY,-0.0082352610641106,-0.4826208549740312,0.0162602206348478,-0.005469643982969,0.0113034803065652,0.0041053550108782,-0.0021686936328561,0.0113877058804048,-0.1891891891891891,0
2011-06-07,Roche and Merck Collaborate to Develop Diagnostic Tests for Merck's Investigational Cancer Therapies   ,RHHBY,-0.0061984657733371,-0.3694984646878199,-0.0077447410041779,0.0015968265326693,0.0018288112337083,-0.0038706073348316,0.0124479119664309,-0.012936067549999,-0.3409090909090909,1
2012-01-25,"Benzinga's M&A Chatter for Wednesday January 25, 2012",RHHBY,-0.0211282847598645,3.777063236870311,0.0111365408685191,0.0057141984516546,-0.0157482228707852,0.0077083216513238,0.0241466039046434,-0.0034445640614167,-0.8657168498990352,2
2012-01-26,"Benzinga's M&A Chatter for Thursday January 26, 2012",RHHBY,-0.0034445640614167,-0.8657168498990352,-0.0211282847598645,0.0111365408685191,0.0057141984516546,-0.0157482228707852,0.0077083216513238,-0.0064515097827307,0.7752715121136173,1
2012-02-09,"Benzinga's M&A Chatter for Thursday February 9, 2012",RHHBY,0.0114630510944007,1.193548387096774,0.0111365408685191,0.0268376331158213,0.0007007904358404,0.0251374909663184,-0.0035782977280434,-0.0168886100644665,-0.4938235294117646,1
2012-02-21,"Benzinga's M&A Chatter for Tuesday February 21, 2012",RHHBY,-0.0022691085011123,0.4489894128970164,-0.0040676401050515,0.0114283969033091,-0.0043242805369395,-0.0194152434284152,0.0128842279896312,-0.0065954061497724,-0.2922617070740617,1
2013-01-09,Will the Flu Season Make Your Portfolio Sick?,RHHBY,0.0075099845679935,-0.369,0.0081538326406349,-0.0013571278079361,0.006831784509981,-0.0013643229392196,0.0158413907355452,0.0107036724425233,-0.1833069202324353,0
2013-04-02,"Benzinga's M&A Chatter for Tuesday April 2, 2013",RHHBY,0.0120069960079713,0.972187732803576,-0.0051195493950177,0.0134900099997683,-0.0068704383538922,0.0058742774815701,0.00051857403221,0.008644014956209,-0.218081087887182,0
2013-07-01,"Benzinga's M&A Chatter for Monday July 1, 2013",RHHBY,0.0017777505286546,-0.1878666833104481,0.0053624484838012,0.0175263090090986,0.0294470727131692,0.0157330416947496,-0.0154893471502108,0.0027428884145896,0.6852136489394405,2
2013-07-30,Alexion Spikes As the Company Hires Goldman Sachs (ALXN),RHHBY,-0.0160930678925883,1.3992248062015502,-0.0038094615416176,-0.0078739975066115,0.0122746540207894,0.0124274510658515,-0.0062549936894763,-0.0071254176282425,-0.066437802907916,1
2013-07-30,Alexion Spikes As Company Hires Goldman Sachs (ALXN),RHHBY,-0.0160930678925883,1.3992248062015502,-0.0038094615416176,-0.0078739975066115,0.0122746540207894,0.0124274510658515,-0.0062549936894763,-0.0071254176282425,-0.066437802907916,1
2013-07-30,"Benzinga's M&A Chatter for Tuesday July 30, 2013",RHHBY,-0.0160930678925883,1.3992248062015502,-0.0038094615416176,-0.0078739975066115,0.0122746540207894,0.0124274510658515,-0.0062549936894763,-0.0071254176282425,-0.066437802907916,1
2013-09-19,"Benzinga's M&A Chatter for Thursday September 19, 2013",RHHBY,0.0041053876732766,-0.4547352905048519,0.034282081332706,0.0007868378140891,-0.001884983179166,-0.0077932425427796,-0.0046538096393147,0.0040882841529723,-0.2797927461139896,2
2013-12-31,A Look at Some 'Legit' OTC Stocks,RHHBY,-0.0039728913675561,-0.5132978723404256,0.0062821961709875,0.0144843982065363,0.0026139564061349,0.0059898545730023,0.0035185651469873,-0.021794888778074,0.9096258932324506,1
2014-08-25,US Stock Futures Rise Ahead Of Economic Data,RHHBY,0.0068832565684207,-0.3616516966067864,-0.0032932028673413,-0.000274317490111,-0.0051855616418454,0.0071466783874192,0.0066409390826813,0.0010939483574392,-0.0320500293140512,2
2015-06-01,16 Biotech Stocks Moving Off The ASCO Conference,RHHBY,-0.037961409597932,-0.6323667280897424,0.0283422888817079,0.0138249418511691,0.0179358605207091,-0.0160195335541403,-0.0094136607950402,-0.0043243150904543,-0.1486106225817798,2
2015-06-01,Top Gainers And Losers From The ASCO Conference,RHHBY,-0.037961409597932,-0.6323667280897424,0.0283422888817079,0.0138249418511691,0.0179358605207091,-0.0160195335541403,-0.0094136607950402,-0.0043243150904543,-0.1486106225817798,2
2015-08-13,"Benzinga's M&A Chatter for Thursday August 13, 2015",RHHBY,0.0071265352022586,-0.2292429792429792,-0.007076107076086,-0.011471767987342,0.015341054315564,-0.0115137173550247,-0.0080778926284552,0.0016982349495928,1.548910891089109,2
2015-09-04,US Stock Futures Tumble; Jobs Report In Focus,RHHBY,-0.0011976761445857,-0.5279626606387877,0.0024010295016969,-0.0014982563625398,-0.0231265778494635,0.0,-0.0197990116859553,0.003896929926163,0.441803751163925,2
2015-12-23,Not All Of Clinton's Policies Are Bad For Pharmaceuticals,RHHBY,0.0123201951427249,-0.0868787276341948,0.0091770276540201,0.0026714655773163,-0.0044327788954897,-0.0199826349252224,0.0200887315096494,0.00231837892478,-0.4774657086871325,2
2016-03-22,"The Market In 5 Minutes: Tuesday, March 22, 2016",RHHBY,0.0006583016321553,0.0849664606076547,0.0082974049175179,-0.0227051837507108,-0.011858999901915,0.0038610038610038,-0.0073457948149989,-0.0009867635116291,-0.2065704933931386,2
2016-05-11,Jefferies Updates Price Targets And Sees 'Rich Catalyst Environment' Ahead For Global Pharma,RHHBY,-0.0022328041932608,-0.023447102202893,0.0142348503962757,0.0214803958362139,-0.0143321444652998,-0.0096774198524077,-0.0155605210968735,0.0038362408004475,-0.3787394713912285,2
2016-06-13,"Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Says Reuters",RHHBY,-0.0249382788749604,0.6345840130505709,-0.0269623948071809,-0.0053635986128405,-0.0032668377377097,0.0080836884009773,0.0099789778513394,-0.0104199552697141,-0.5828343313373254,1
2016-06-13,"Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Say Regulators",RHHBY,-0.0249382788749604,0.6345840130505709,-0.0269623948071809,-0.0053635986128405,-0.0032668377377097,0.0080836884009773,0.0099789778513394,-0.0104199552697141,-0.5828343313373254,1
2016-09-21,"The Market In 5 Minutes: We're Waiting For You, Mrs. Yellen",RHHBY,0.0083440821735953,0.4186501958421211,0.0107038601534328,0.0075163138254983,-0.0026075360214569,0.005242411597071,0.0003277875103162,0.0041375173024316,0.089731336943825,2
2016-11-29,Wall Street's M&A Chatter From November 28,RHHBY,-0.0025107033759775,-0.3023388476896749,-0.0049965729033851,0.0218819252669311,-0.0122478669733047,-0.0293705474123726,-0.0024416876130886,-0.0017978857626842,0.029212814985505,2
2016-11-29,"The Market In 5 Minutes: OPEC, Tiffany's And More Theranos Trouble",RHHBY,-0.0025107033759775,-0.3023388476896749,-0.0049965729033851,0.0218819252669311,-0.0122478669733047,-0.0293705474123726,-0.0024416876130886,-0.0017978857626842,0.029212814985505,2
2016-12-12,What We Know About Trump's Potential Pick To Head The FDA,RHHBY,-0.0050251825509679,-0.301544775694009,0.028803725016907,-0.0131196210377114,-0.0118832426021483,0.0036138782949475,0.0172793814529041,0.0230880518376532,2.705296662041949,0
2017-01-11,Here's What Merck's Keytruda News Means For Bristol-Myers,RHHBY,-0.0170057487286365,-0.1236120749479527,-0.0009993338040109,0.008059100282828,-0.0046791975317668,0.0236060511700824,0.0100205392346306,-0.0023745184704594,0.0101949915866574,2
2017-01-26,Merck's Keytruda Gains Momentum At The Expense Of Bristol-Myers,RHHBY,0.0034002315705083,0.543180930050801,0.0120439374342493,-0.0047944935171949,0.0003425284727816,0.0079419612130864,-0.0136240046057469,0.0057607326812632,-0.4605596353507217,0
2017-02-01,Wall Street's M&A Chatter From January 31,RHHBY,0.0043390653940103,-0.4415417057169635,0.0159376600162597,-0.0064014838547583,0.0057607326812632,0.0034002315705083,0.0120439374342493,-0.0176137987058906,0.8394168239983217,1
2017-02-01,"The Market In 5 Minutes: Neil Gorsuch, Apple And #TheFinalYolo",RHHBY,0.0043390653940103,-0.4415417057169635,0.0159376600162597,-0.0064014838547583,0.0057607326812632,0.0034002315705083,0.0120439374342493,-0.0176137987058906,0.8394168239983217,1
2017-02-15,Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers,RHHBY,0.0158302999830008,1.6567386448250183,-0.0043595169999917,-0.006,-0.0003331691653292,0.0020032590178387,-0.0003338049535283,0.0116047478054364,-0.7769058295964125,0
2017-02-16,"After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?",RHHBY,0.0116047478054364,-0.7769058295964125,0.0158302999830008,-0.0043595169999917,-0.006,-0.0003331691653292,0.0020032590178387,0.0006554966588085,0.023151471643934,2
2017-03-02,Why Bermuda Could Be The Next Switzerland,RHHBY,0.0612110755266435,3.1187538556446635,0.004273451541862,0.002967516938124,-0.0088236075431128,0.001964714980895,-0.0022868605222061,0.0,-0.5545195836141691,2
2017-05-19,The Most Notable Abstracts Released Ahead Of ASCO 2017,RHHBY,0.014792987377356,-0.5405543492144591,-0.006466814336689,-0.0104713614669308,0.0144587279932579,0.0041481425778724,0.0141225668411988,0.0037900435120137,0.6238532110091743,2
2017-05-23,The Current State Of The Breast Cancer Treatment Space,RHHBY,-0.0037757333184471,0.0409176510871425,0.0037900435120137,0.014792987377356,-0.006466814336689,-0.0104713614669308,0.0144587279932579,-0.0023323292757181,0.2601973684210525,2
2017-09-01,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,RHHBY,-0.0018898651749821,-0.0781685828967957,0.0117910173291788,-0.0128971502962055,0.004423447880774,0.0015821924463665,0.0066900932059936,-0.0012622469705962,-0.3650184501845018,2
2018-02-08,The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,RHHBY,-0.0010335488999767,0.1819265143992054,-0.0135915419704568,0.0078767919850459,-0.0266666841627182,-0.0053050432499802,-0.0270967368924834,-0.0006896656355351,-0.2559233742228197,2
2018-03-05,7 Biotech Stocks With Clinical Trial Outcomes In March,RHHBY,0.023964521738965,-0.6829209955901039,0.0181247335968932,-0.007609778900299,-0.0216582213865493,-0.0110441507183874,0.0043696972984996,0.001671668174177,1.0169251803309605,2
2018-05-21,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More",RHHBY,0.018259909473582,-0.5704024601019058,-0.0007155906336321,-0.0130649164018327,0.0042552430744224,0.0049894187213108,0.0122654138505866,-0.0105484530441516,-0.2735252625529024,1
2018-06-05,"Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index",RHHBY,-0.0129629599029713,-0.2932187752277707,-0.0138787013543357,0.0212606150185377,-0.0121592244082699,-0.0022058839208227,-0.0069367757597831,-0.0015008277152739,0.0291262135922329,2
2018-06-08,"Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",RHHBY,-0.0078947845111271,-0.0976902688375614,-0.0003758128115199,-0.0015008277152739,-0.0129629599029713,-0.0138787013543357,0.0212606150185377,0.0071997165218338,-0.0642047838858581,0
2018-07-17,"Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4",RHHBY,-0.0010313212944267,0.4931207406454931,0.0013769885493863,0.0114902987544474,0.0242509540284312,-0.0081357472918718,0.0028379144355701,0.0061940090445273,0.1414054426455391,0
2018-07-18,"Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Cocktail Clears FDA Hurdle, Cara To Offer Shares",RHHBY,0.0061940090445273,0.1414054426455391,-0.0010313212944267,0.0013769885493863,0.0114902987544474,0.0242509540284312,-0.0081357472918718,-0.011285880751559,1.127961370152407,1
2018-07-26,"Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold",RHHBY,0.0019815074529565,-0.1310369965372698,0.028183448590445,0.002041436392171,-0.0027145768051061,0.0193704238031564,-0.011285880751559,0.0085695026493088,-0.0075503355704698,0
2018-08-27,AbbVie's Rare Blood Cancer Drug Combo Snags FDA Approval,RHHBY,0.0091562939007012,-0.2800705467372134,0.0019659254690809,-0.0045662376202829,-0.0064808382065276,0.010478094325127,0.0139441593733327,0.0022683222865267,0.1731994120529152,2
2018-09-04,"The Week Ahead: Mr. Dorsey Goes To Washington, Employment And Wage Data On Tap",RHHBY,-0.0019379860321189,0.5461378952825298,-0.0054608912846447,-0.0019237665486621,0.0084060365256144,0.0022683222865267,0.0091562939007012,-0.0129449700345308,-0.4884325230511316,1
2018-09-05,"The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin's Debt Offering, ProQR And Bluebird Report Positive Trial Results",RHHBY,-0.0129449700345308,-0.4884325230511316,-0.0019379860321189,-0.0054608912846447,-0.0019237665486621,0.0084060365256144,0.0022683222865267,-0.0009836438941415,-0.1125675897099787,2
2018-09-26,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,RHHBY,-0.0003273446710105,0.3854885377253505,0.0125953283833271,-0.0146963247895938,0.0006536195952908,0.0016366503359426,-0.0039126212766037,-0.0075311006224579,-0.2446586345381526,1
2018-10-04,"The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut",RHHBY,0.0,-0.6434450132849459,0.0039331396959914,0.0039487440615608,0.007625988760237,-0.0049489025061864,-0.0075311006224579,0.0071824820325065,1.5023627771719377,0
2018-10-10,"The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",RHHBY,-0.0065124934897583,0.4032287653641533,-0.0022742902291763,-0.0022689852800492,0.0071824820325065,0.0,0.0039331396959914,-0.0288430731804969,0.664662047326448,1
2018-10-12,"The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program",RHHBY,0.0023626355756212,-0.2624676038639755,-0.0288430731804969,-0.0065124934897583,-0.0022742902291763,-0.0022689852800492,0.0071824820325065,-0.0006735012737714,-0.2080715578745607,2
2018-10-22,11 Stocks That Moved From ESMO 2018,RHHBY,0.0035947619745027,-0.2795024337479719,0.0254691642911544,0.001342257965198,-0.0302635735760324,0.0353773483865773,-0.0006735012737714,0.0029306075426551,0.5487164089476055,2
2018-11-30,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,RHHBY,0.0182103506881374,0.8152810768012668,-0.0037533825588004,0.019126425639343,-0.0022264057152762,0.0125604327724335,0.0009671547793548,0.002466738818714,-0.4548349108038557,2
2018-12-04,"The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO",RHHBY,-0.0169178969840079,-0.2096167693415472,0.002466738818714,0.0182103506881374,-0.0037533825588004,0.019126425639343,-0.0022264057152762,-0.0090738384810404,5.2941593278671935,1
2018-12-06,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",RHHBY,-0.0090738384810404,5.2941593278671935,-0.0169178969840079,0.002466738818714,0.0182103506881374,-0.0037533825588004,0.019126425639343,-0.0053677784390229,-0.8787552267610164,1
2019-01-17,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",RHHBY,-0.0006164774909386,-0.528971028971029,-0.0015390620413787,0.0049489442827188,-0.0024682612547957,-0.0058281688876383,0.0067941615679454,0.0058605960614406,0.616118769883351,0
2019-01-30,"The Daily Biotech Pulse: Roche Scraps Alzheimer's Disease Trials, Amgen Issues Weak Guidance",RHHBY,0.000309827975655,-0.6675155443841778,0.0043572553658239,0.0021834193306922,-0.0003117601825487,-0.0126232191904634,0.0083825310206004,0.0315984701090641,0.3668556649756291,0
2019-02-05,"The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results",RHHBY,0.0020951939136018,-0.6161357546888955,0.0121175273035132,-0.0087086381389059,0.0315984701090641,0.000309827975655,0.0043572553658239,-0.0005973942523557,1.0532030401737242,2
2019-02-25,"Pharma M&A Wave: Spark Therapeutics, Clementia Pharma Among The Rare Disease Biotechs Acquired",RHHBY,-0.0037431754025517,1.5151748574949933,0.0049188451228616,-0.0017329105119315,0.0078601709774706,0.0097000850065585,0.0080000391287222,0.0060694660873634,-0.3882763689819919,0
2019-02-26,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",RHHBY,0.0060694660873634,-0.3882763689819919,-0.0037431754025517,0.0049188451228616,-0.0017329105119315,0.0078601709774706,0.0097000850065585,-0.0002874128365301,1.1594072293982176,2
2019-03-04,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,RHHBY,-0.0002872390602045,0.5353358364622445,0.0043287819287018,-0.0043101243403469,-0.0002874128365301,0.0060694660873634,-0.0037431754025517,0.0014371209107086,-0.6707244171512418,2
2019-03-06,"The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",RHHBY,-0.0005740746455829,-0.4743356989602244,0.0014371209107086,-0.0002872390602045,0.0043287819287018,-0.0043101243403469,-0.0002874128365301,-0.0067009148187621,1.7642072213500786,1
2019-04-26,"The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug",RHHBY,0.0064714871176836,-0.4942719881744272,-0.0097650426716223,-0.0036484650274741,0.0126230871905503,-0.0064239096977757,-0.0009169542301431,-0.0003061688322643,0.0133357690902446,2
2019-04-30,"The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering",RHHBY,0.0125574283735623,1.2428339643050297,-0.0003061688322643,0.0064714871176836,-0.0097650426716223,-0.0036484650274741,0.0126230871905503,-0.0003025297802956,-0.412748171368861,2
2019-05-10,"The Daily Biotech Pulse: FibroGen Kidney Disease Trial Disappoints, Medtronic To Buy Titan Spine, Puma's Weak Breast Cancer Drug Sales",RHHBY,-0.0021786019154912,-0.0481927710843373,-0.0144170839057501,0.003694453397248,-0.0160556822496596,-0.0066205009060023,0.0097234365329488,-0.0021834933723876,0.0854785947944816,2
2019-05-14,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",RHHBY,0.0012503250426354,-0.0592243186582809,-0.0021834933723876,-0.0021786019154912,-0.0144170839057501,0.003694453397248,-0.0160556822496596,0.0003123258345001,0.3714484679665737,2
2019-05-15,"The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",RHHBY,0.0003123258345001,0.3714484679665737,0.0012503250426354,-0.0021834933723876,-0.0021786019154912,-0.0144170839057501,0.003694453397248,0.0177902030711398,1.3373616329846656,0
2019-05-16,5 ASCO Abstracts That Moved Stocks,RHHBY,0.0177902030711398,1.3373616329846656,0.0003123258345001,0.0012503250426354,-0.0021834933723876,-0.0021786019154912,-0.0144170839057501,0.0070530781733502,-0.4752346193952033,0
2019-05-16,"The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics",RHHBY,0.0177902030711398,1.3373616329846656,0.0003123258345001,0.0012503250426354,-0.0021834933723876,-0.0021786019154912,-0.0144170839057501,0.0070530781733502,-0.4752346193952033,0
2019-06-04,"The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-tender Offer",RHHBY,-0.0009032948793251,-0.4309635942289004,0.0100364280591009,-0.0051436473970511,-0.0003025297802956,-0.0054152023474348,-0.0223527846230046,0.0027123997949534,0.1416184971098266,2
2019-06-11,"The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering",RHHBY,-0.0035069153957134,1.84714982344039,-0.0005840814089336,0.0130178345432743,0.0159302748087191,0.0027123997949534,-0.0009032948793251,0.015835833390148,-0.4290692180486652,0
2019-06-12,"The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana",RHHBY,0.015835833390148,-0.4290692180486652,-0.0035069153957134,-0.0005840814089336,0.0130178345432743,0.0159302748087191,0.0027123997949534,0.0023095346537482,-0.0535326368056273,2
2019-06-21,"The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy",RHHBY,-0.0044743401099066,-0.3358624663849404,0.0150438795920493,0.0111941240321817,0.0116143558806425,-0.0031838117701914,-0.004896304814515,-0.0058988705398413,0.0228488792480114,1
2019-07-09,"The Daily Biotech Pulse: Roche Presents Positive Hemlibra Data, Amgen's Tender Offer For Nuevolution Complete, Genmab Offering",RHHBY,0.0,2.6487613441255826,-0.0091375871878445,-0.0168444337739832,0.0025330591770398,0.0053763059564158,0.0068376787066009,0.0011527393671422,-0.7938289862866362,2
2019-07-23,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",RHHBY,0.0071238503564938,0.0848498136373603,0.0014863119411718,-0.0240789592037636,0.0087797395664517,0.0151514247014843,0.0032787094284583,-0.0002947726098997,0.975141471301536,2
2019-07-31,"The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster",RHHBY,0.0020907550447846,-0.2812140722005058,-0.0123894293763583,0.0011814643023257,0.0177336715121574,-0.0191627479990605,-0.0002947726098997,0.0056632780679963,-0.2146513115802942,0
2019-08-28,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,RHHBY,-0.0043528947119765,-0.1960087479496992,-0.0002900920829244,0.0017437131042519,-0.0043403618958425,-0.0063254521905312,0.002016790674072,-0.0020401772020194,-0.1458687521251275,2
2019-08-29,"The Daily Biotech Pulse: EC Approves Roche's Tecentriq For Breast Cancer, Trevena On Track For NDA Resubmission, Edap Earnings",RHHBY,-0.0020401772020194,-0.1458687521251275,-0.0043528947119765,-0.0002900920829244,0.0017437131042519,-0.0043403618958425,-0.0063254521905312,-0.001752433535814,8.084792993630574,2
2019-09-18,"The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts",RHHBY,0.0031267348357506,0.182832105158335,0.0214867058100951,-0.001449744568814,0.0171041557378559,-0.0005894815402552,-0.0107871092394181,0.0099177307194708,-0.0020205421788179,0
2019-09-20,"The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering",RHHBY,0.0019641034302515,0.4258478150835161,0.0099177307194708,0.0031267348357506,0.0214867058100951,-0.001449744568814,0.0171041557378559,0.0002801399077994,-0.4373446929357473,2
2019-09-25,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",RHHBY,-0.0022441635112031,1.234561063417336,-0.0019596438102245,0.0002801399077994,0.0019641034302515,0.0099177307194708,0.0031267348357506,0.0188360800237579,2.695377370182179,0
2019-09-30,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,RHHBY,-0.0002741402538517,0.3561154002438034,0.0060706194147137,0.0188360800237579,-0.0022441635112031,-0.0019596438102245,0.0002801399077994,-0.0065844897684331,-0.8333912626595553,1
2019-09-30,Stocks That Hit 52-Week Highs On Monday,RHHBY,-0.0002741402538517,0.3561154002438034,0.0060706194147137,0.0188360800237579,-0.0022441635112031,-0.0019596438102245,0.0002801399077994,-0.0065844897684331,-0.8333912626595553,1
2019-10-29,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",RHHBY,-0.00189088698463,-0.6059687415790892,0.0005406289234721,0.0081743099205953,0.0060307399410275,0.0060673304330054,-0.0127961124590562,0.0148848980431965,0.0220550521456659,0
2019-10-30,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",RHHBY,0.0148848980431965,0.0220550521456659,-0.00189088698463,0.0005406289234721,0.0081743099205953,0.0060307399410275,0.0060673304330054,0.0031999470843133,0.0215791234526596,2
2019-11-01,"The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance",RHHBY,0.0021266465458074,-0.5362698542655968,0.0031999470843133,0.0148848980431965,-0.00189088698463,0.0005406289234721,0.0081743099205953,-0.0029178476197179,6.1366525423728815,2
2019-11-08,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut",RHHBY,0.0061893582669052,-0.2061923583662713,0.0013472748135532,0.0029730503080382,-0.0156956438619056,-0.0029178476197179,0.0021266465458074,0.0045467783877493,-0.3190041493775933,2
2019-11-22,"The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate",RHHBY,-0.0041852009639097,-0.2425670465255762,0.0015719457552483,-0.0033943030678027,0.0070997399723928,0.0133226665413916,0.0050882248683619,0.0107696364335374,0.2869909502262444,0
2019-11-26,Stocks That Hit 52-Week Highs On Tuesday,RHHBY,0.0077961849531822,0.0412235211391402,0.0107696364335374,-0.0041852009639097,0.0015719457552483,-0.0033943030678027,0.0070997399723928,-0.0059309152285288,1.8108222184703695,1
2019-11-29,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,RHHBY,0.0005188916232798,-0.9056371444874912,-0.0059309152285288,0.0077961849531822,0.0107696364335374,-0.0041852009639097,0.0015719457552483,-0.0038890526506607,1.079885423297263,2
2019-12-11,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",RHHBY,0.0023436265646121,2.247051114023591,0.0,-0.0044074510896618,0.0036430208399278,-0.0023365500347375,0.0086410034544326,-0.0012990827270161,-0.1843255970400269,2
2019-12-12,"The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win",RHHBY,-0.0012990827270161,-0.1843255970400269,0.0023436265646121,0.0,-0.0044074510896618,0.0036430208399278,-0.0023365500347375,-0.0072841463470842,-0.1571134020618556,1
2019-12-13,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",RHHBY,-0.0072841463470842,-0.1571134020618556,-0.0012990827270161,0.0023436265646121,0.0,-0.0044074510896618,0.0036430208399278,0.0117926272327395,-0.0584148727984344,0
2019-12-17,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",RHHBY,0.0010359465390701,-0.3140392808895355,0.0117926272327395,-0.0072841463470842,-0.0012990827270161,0.0023436265646121,0.0,0.0072445684743427,0.891228601727011,0
2019-12-18,Stocks That Hit 52-Week Highs On Wednesday,RHHBY,0.0072445684743427,0.891228601727011,0.0010359465390701,0.0117926272327395,-0.0072841463470842,-0.0012990827270161,0.0023436265646121,0.0115591556593741,-0.1820730535084909,0
2019-12-19,Stocks That Hit 52-Week Highs On Thursday,RHHBY,0.0115591556593741,-0.1820730535084909,0.0072445684743427,0.0010359465390701,0.0117926272327395,-0.0072841463470842,-0.0012990827270161,0.0126967914336983,-0.1384781118401723,0
2019-12-19,"The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",RHHBY,0.0115591556593741,-0.1820730535084909,0.0072445684743427,0.0010359465390701,0.0117926272327395,-0.0072841463470842,-0.0012990827270161,0.0126967914336983,-0.1384781118401723,0
2019-12-20,Stocks That Hit 52-Week Highs On Friday,RHHBY,0.0126967914336983,-0.1384781118401723,0.0115591556593741,0.0072445684743427,0.0010359465390701,0.0117926272327395,-0.0072841463470842,0.0117852784953749,2.9906786404456063,0
2019-12-20,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering",RHHBY,0.0126967914336983,-0.1384781118401723,0.0115591556593741,0.0072445684743427,0.0010359465390701,0.0117926272327395,-0.0072841463470842,0.0117852784953749,2.9906786404456063,0
2019-12-23,Stocks That Hit 52-Week Highs On Monday,RHHBY,0.0117852784953749,2.9906786404456063,0.0126967914336983,0.0115591556593741,0.0072445684743427,0.0010359465390701,0.0117926272327395,-0.0002477113739467,-0.9052013900757704,2
2019-12-27,Stocks That Hit 52-Week Highs On Friday,RHHBY,0.006937518435897,4.554563275974733,0.0004957597437731,-0.0002477113739467,0.0117852784953749,0.0126967914336983,0.0115591556593741,0.0022145569344331,-0.2337555389984706,2
2020-01-10,Stocks That Hit 52-Week Highs On Friday,RHHBY,0.0041604352852375,1.587446216147811,0.0004897960738436,0.0034397288308352,-0.007801083947404,0.0091020372800618,-0.0058694138639023,0.0034121691360782,-0.4929081482930646,2
2020-01-15,Stocks That Hit 52-Week Highs On Wednesday,RHHBY,0.0087419621107136,0.2417234664070107,0.0002430924891347,0.0034121691360782,0.0041604352852375,0.0004897960738436,0.0034397288308352,0.0050554148239529,0.860419525583219,0
2020-01-16,Stocks That Hit 52-Week Highs On Thursday,RHHBY,0.0050554148239529,0.860419525583219,0.0087419621107136,0.0002430924891347,0.0034121691360782,0.0041604352852375,0.0004897960738436,0.0160478884242938,-0.4409905163329821,0
2020-01-17,Stocks That Hit 52-Week Highs On Friday,RHHBY,0.0160478884242938,-0.4409905163329821,0.0050554148239529,0.0087419621107136,0.0002430924891347,0.0034121691360782,0.0041604352852375,0.0007071764041455,0.7157398680490104,2
2020-01-17,9 Takeaways From The JPMorgan Healthcare Conference,RHHBY,0.0160478884242938,-0.4409905163329821,0.0050554148239529,0.0087419621107136,0.0002430924891347,0.0034121691360782,0.0041604352852375,0.0007071764041455,0.7157398680490104,2
2020-01-21,Stocks That Hit 52-Week Highs On Tuesday,RHHBY,0.0007071764041455,0.7157398680490104,0.0160478884242938,0.0050554148239529,0.0087419621107136,0.0002430924891347,0.0034121691360782,0.0030624691172527,0.0865743792573061,2
2020-01-22,Stocks That Hit 52-Week Highs On Wednesday,RHHBY,0.0030624691172527,0.0865743792573061,0.0007071764041455,0.0160478884242938,0.0050554148239529,0.0087419621107136,0.0002430924891347,-0.0044622587032261,-0.6076845298281093,2
2020-01-24,"The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study",RHHBY,-0.0280725100746098,4.5471649484536085,-0.0044622587032261,0.0030624691172527,0.0007071764041455,0.0160478884242938,0.0050554148239529,-0.0055825449944211,-0.1605724109092599,1
2020-02-11,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",RHHBY,-0.0004605864283119,1.6641141141141145,0.0025393088622935,-0.0025328771050138,-0.0029843316388755,0.0276009293382242,0.01241936018219,-0.0004606991198735,0.4135715493434031,2
2020-02-14,"The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering",RHHBY,-0.0066392404336964,2.525339750849377,0.0066836145577111,-0.0004606991198735,-0.0004605864283119,0.0025393088622935,-0.0025328771050138,0.0163631536143804,-0.6786330964140866,0
2020-02-19,Stocks That Hit 52-Week Highs On Wednesday,RHHBY,0.0142857478817819,0.7672122953892291,0.0163631536143804,-0.0066392404336964,0.0066836145577111,-0.0004606991198735,-0.0004605864283119,-0.0194499774226152,-0.1386551650993424,1
2020-02-19,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA",RHHBY,0.0142857478817819,0.7672122953892291,0.0163631536143804,-0.0066392404336964,0.0066836145577111,-0.0004606991198735,-0.0004605864283119,-0.0194499774226152,-0.1386551650993424,1
2020-02-26,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",RHHBY,0.0095809555866206,1.042933249764964,-0.0185706958756629,-0.0338405529764864,0.0038758635937203,-0.0194499774226152,0.0142857478817819,-0.0325030982084932,-0.3955616914659713,1
2020-02-27,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",RHHBY,-0.0325030982084932,-0.3955616914659713,0.0095809555866206,-0.0185706958756629,-0.0338405529764864,0.0038758635937203,-0.0194499774226152,-0.0218244422902731,3.549868877421538,1
2020-03-11,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",RHHBY,-0.0425324746658735,-0.7555894846638751,0.0336028082513784,-0.0582916154864571,-0.0245996861069743,-0.0126031468803258,0.0492908100229509,-0.0896093779476533,1.0194210786739235,1
2020-03-12,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",RHHBY,-0.0896093779476533,1.0194210786739235,-0.0425324746658735,0.0336028082513784,-0.0582916154864571,-0.0245996861069743,-0.0126031468803258,0.1301177904081447,2.492955589586524,0
2020-03-13,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",RHHBY,0.1301177904081447,2.492955589586524,-0.0896093779476533,-0.0425324746658735,0.0336028082513784,-0.0582916154864571,-0.0245996861069743,-0.073449025349805,-0.4540400719014424,1
2020-03-17,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",RHHBY,0.0522227292406338,-0.2674579211101118,-0.073449025349805,0.1301177904081447,-0.0896093779476533,-0.0425324746658735,0.0336028082513784,-0.0402137704208361,0.2921663633772555,1
2020-03-19,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",RHHBY,0.0654010810454024,1.6411761711658213,-0.0402137704208361,0.0522227292406338,-0.073449025349805,0.1301177904081447,-0.0896093779476533,-0.0734275049721536,-0.721372452027778,1
2020-04-03,"The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO",RHHBY,-0.0127251072068405,-0.0818702142470415,0.0208334253186894,0.0056691631292913,-0.0075832401957539,0.0490120836765819,0.0048993696566412,0.0128891226746779,-0.0238827345099195,0
2020-04-15,"The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US",RHHBY,-0.0174018153442663,-0.3304803839113441,0.0357957930745924,-0.0090565823766839,-0.0148698197728173,0.0082457436578571,-0.0391356140756926,0.0424045616258916,0.1331929357865957,0
2020-04-28,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",RHHBY,0.0086877973828443,0.0769416014449126,-0.003772689550734,0.0199185106149748,-0.0103047542717495,0.0297578682642623,0.0032399236309947,-0.0331271479570901,0.0024970184853905,1
2020-06-04,"The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",RHHBY,-0.0145653557017045,0.9345848568625704,0.0031963766873206,0.0085194390277665,0.0018454611811937,-0.0136519080395257,0.0199582168585485,-0.0080831192031746,-0.5523337559064192,1
2020-06-30,"The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test",RHHBY,-0.0073227218544862,0.1645919778699862,-0.0045557553975714,-0.0183363895075453,0.0271015737471593,-0.0287753595004196,-0.0013366129283937,0.0149838093003087,-0.7723108245673567,0
2020-07-07,"The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold",RHHBY,-0.0063795489424562,-0.0357634112792296,0.0022835517021304,-0.0054506895094635,0.0149838093003087,-0.0073227218544862,-0.0045557553975714,0.0116944811866648,0.1233158979236013,0
2020-07-14,"The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits",RHHBY,0.0065625368847621,-0.1743217835079237,-0.000904371948822,-0.0060674717088562,0.0086129541276109,0.0116944811866648,-0.0063795489424562,0.0056205560050848,-0.2115593146822815,0
2020-07-16,AC Immune Surge Higher On Alzheimer's Trial Update,RHHBY,0.0044713135359228,-0.1742538852977582,0.0056205560050848,0.0065625368847621,-0.000904371948822,-0.0060674717088562,0.0086129541276109,0.012241190702726,1.3980679546968688,0
2020-07-29,"The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More",RHHBY,0.0060702004854917,0.9473684210526316,0.0159889931177321,0.019324780263888,-0.0245286736848996,-0.0520991497371863,0.0258393715532647,-0.0080446736791414,-0.6067055523398193,1
2020-07-31,"The Daily Biotech Pulse: Sanofi-GSK Land $2.1M Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche",RHHBY,-0.0290606792600272,-0.3429186007019132,-0.0080446736791414,0.0060702004854917,0.0159889931177321,0.019324780263888,-0.0245286736848996,0.024594099811098,0.8680220537560304,0
2020-08-19,"A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Lowe's, Target Earnings",RHHBY,0.0059686408800734,-0.0281130200198779,0.0050761887463735,0.0185664658545372,-0.0152742858051457,-0.0036891236875047,0.0284563155649006,0.0152898681869342,1.3706355003652302,0
2020-08-19,"The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs",RHHBY,0.0059686408800734,-0.0281130200198779,0.0050761887463735,0.0185664658545372,-0.0152742858051457,-0.0036891236875047,0.0284563155649006,0.0152898681869342,1.3706355003652302,0
2020-08-24,Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week,RHHBY,0.0013673782055265,-0.3282467185999359,-0.0137109786419816,0.0152898681869342,0.0059686408800734,0.0050761887463735,0.0185664658545372,-0.0031861924161603,0.1887212073073867,2
2020-08-31,Pharmaceutical Companies Are Doing Much More Than Battling COVID-19,RHHBY,0.0064487009103786,-0.0059874548564912,-0.0025269202274305,-0.0198154457557891,0.0139269742035432,-0.0031861924161603,0.0013673782055265,0.0183066129017723,0.646620135768238,0
2020-09-02,The Benefits Of Unsponsored ADRs,RHHBY,0.0141572456997951,-0.0505167808616885,0.0183066129017723,0.0064487009103786,-0.0025269202274305,-0.0198154457557891,0.0139269742035432,-0.0292487368914221,-0.4916829745596869,1
2020-09-11,"The Daily Biotech Pulse: Positive Readout From Galapagos, Intersect ENT Strikes Distribution Deal, Sol Gel's Regulatory Filing Accepted For Review",RHHBY,0.0154883596799919,0.117611212675198,-0.0077951722276333,0.0232452385460115,0.0022841692145472,-0.0006848770783346,-0.0292487368914221,-0.0011053193586739,0.7300981461286804,2
2020-09-18,"The Daily Biotech Pulse: Roche's COVID Combo Therapy Reduces Need For Ventilation, ESMO Presentations",RHHBY,0.0103538496058523,2.4975203684024088,0.0076071132905817,-0.0006517952760447,0.0188095527912801,-0.0011053193586739,0.0154883596799919,-0.0115287142332637,-0.4113536233351902,1
2020-09-30,Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates,RHHBY,-0.0129120778012818,-0.4537194775695627,-0.0167763007932407,-0.015841101992955,0.0026845886672006,-0.0035666847808779,-0.0313107495457565,-0.000467184862819,0.3355278355278355,2
2020-10-13,"The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data",RHHBY,-0.0047836433694476,-0.3816366520481478,-0.002952464746686,0.0246683092772006,0.0067948150014611,-0.0058234874839177,-0.0149151401833221,-0.0061798654598183,0.2183491776067603,1
2020-10-22,"The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat",RHHBY,-0.0031644843486521,-0.2242459205538157,-0.0244598726665946,-0.0059017495284208,-0.0032940495961617,0.0083036547053645,-0.0292491753871816,0.0019535176361362,0.7351535111016678,2
2020-11-03,Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates,RHHBY,0.0179873232527771,0.7951647936537918,0.0287571401258706,-0.0052238248348132,0.0027437471229894,-0.027177815893402,-0.0004849866011401,0.0553963857739328,0.5119154084907149,0
2020-11-05,"The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping",RHHBY,0.001131232227048,-0.7457898399443285,0.0553963857739328,0.0179873232527771,0.0287571401258706,-0.0052238248348132,0.0027437471229894,-0.0024858040950441,1.5629619490829456,2
2020-11-11,"The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap",RHHBY,0.0265316385910003,0.4129722135497971,-0.0133269113180641,-0.0480290611696657,-0.0024858040950441,0.001131232227048,0.0553963857739328,0.0021145825776389,-0.3464619123902115,2
2020-12-18,"The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data",RHHBY,0.0071002901105075,1.1656969637705958,0.0034475152037778,0.0116252136096108,0.0077320308637316,-0.0122657922159615,0.0006948695882496,-0.0177393411412197,-0.4606614742070211,1
2020-12-23,"The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut",RHHBY,-0.0079383361371876,-0.3993085002283254,-0.0083352426019156,-0.0177393411412197,0.0071002901105075,0.0034475152037778,0.0116252136096108,0.0014120113150211,-0.6081125108601216,2
2021-01-07,Moderna Hires Amgen Executive As Chief Commercial Officer To Bolster Vaccine Marketing,RHHBY,-0.0176702779321109,0.8584283771057863,-0.0173635548066899,-0.0025067645694949,0.0009124172166286,0.0,0.0122372775706562,0.0092307551961916,-0.283542593322448,0
2021-01-12,"The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue",RHHBY,0.0068445948451767,0.1024343977236801,0.0279080305370151,0.0092307551961916,-0.0176702779321109,-0.0173635548066899,-0.0025067645694949,-0.0024925636524107,0.5361342127903641,2
2021-02-03,"The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision",RHHBY,-0.0029968004898254,-0.4193569596949175,-0.0027586461946689,0.0020731775107818,-0.0260264329652673,0.0022487277542464,-0.0269146350149869,0.0104047210301676,0.794587249462122,0
2021-02-04,"The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs",RHHBY,0.0104047210301676,0.794587249462122,-0.0029968004898254,-0.0027586461946689,0.0020731775107818,-0.0260264329652673,0.0022487277542464,-0.0169336984212777,-0.2412922766279657,1
2021-02-17,"The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal",RHHBY,-0.0165632038648471,-0.0086193973916953,-0.0059455345692871,0.0004574695636097,0.0011452235589612,-0.004332897865251,0.0240542081876411,0.0021053807550324,-0.5479322597716791,2
2021-02-25,"The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants",RHHBY,-0.0235804812383843,0.8795593635250918,0.0026539255063384,-0.0133301833901193,-0.0037941025553143,-0.0156397329347082,0.0021053807550324,0.012814210008387,0.0365980724146912,0
2021-03-05,"The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study",RHHBY,0.0022223463525341,-0.2797218927112165,0.0037175068564407,-0.0170524314632868,0.0019525639941473,-0.0031629444393082,0.012814210008387,-0.0115793130667917,-0.2049041584701953,1
2021-03-16,"The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study",RHHBY,-0.0021402293578255,0.500873786407767,0.0248598854169539,-0.0155950532942055,-0.0064361935220224,0.020184808277484,0.0249252471269678,0.0114393715504366,0.0239989650042047,0
2021-03-17,"The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes",RHHBY,0.0114393715504366,0.0239989650042047,-0.0021402293578255,0.0248598854169539,-0.0155950532942055,-0.0064361935220224,0.020184808277484,-0.0046644069188637,-0.2857864813644978,2
2021-03-23,Pfizer Starts Early-Stage Study Of Oral Antiviral COVID-19 Drug,RHHBY,-0.0317647052074892,0.3045026943099826,0.0315533408477006,0.0056138589371781,-0.0046644069188637,0.0114393715504366,-0.0021402293578255,-0.0119076195513924,-0.0359168241965973,1
2021-03-23,"The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO",RHHBY,-0.0317647052074892,0.3045026943099826,0.0315533408477006,0.0056138589371781,-0.0046644069188637,0.0114393715504366,-0.0021402293578255,-0.0119076195513924,-0.0359168241965973,1
2021-03-30,"The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings",RHHBY,-0.0032193998778612,0.2795894464307731,-0.0017305693912821,-0.0049200710852413,-0.0002459330606384,-0.0119076195513924,-0.0317647052074892,0.0077018878579526,-0.5900277008310248,0
2021-03-30,"Apple, Netflix, Peloton, Square, Roku, DraftKings - What Cathie Wood's Ark Bought And Sold On Monday",RHHBY,-0.0032193998778612,0.2795894464307731,-0.0017305693912821,-0.0049200710852413,-0.0002459330606384,-0.0119076195513924,-0.0317647052074892,0.0077018878579526,-0.5900277008310248,0
2021-04-13,"The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug",RHHBY,0.0028865927385361,0.4094776414721013,-0.0085857185135569,0.0128018613180271,0.0189515276158931,-0.0056289721271159,-0.014233992150346,-0.001199285126652,-0.3488453709552888,2
2021-04-15,"The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split",RHHBY,0.0050432407420237,-0.1732241026193812,-0.001199285126652,0.0028865927385361,-0.0085857185135569,0.0128018613180271,0.0189515276158931,0.006212731161824,0.1707953063885268,0
2021-04-16,"The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs",RHHBY,0.006212731161824,0.1707953063885268,0.0050432407420237,-0.001199285126652,0.0028865927385361,-0.0085857185135569,0.0128018613180271,0.0040369962463018,-0.1250556792873051,2
2021-04-23,"The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs",RHHBY,-0.0035277197777257,-0.1763956451239287,-0.0155128542483364,0.0278438438693975,-0.0061494496555855,0.0040369962463018,0.006212731161824,-0.0139250188489545,1.9251863310364223,1
2021-04-28,"The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping",RHHBY,-0.0083631911237432,0.1317413803853109,0.0016754795972819,-0.0139250188489545,-0.0035277197777257,-0.0155128542483364,0.0278438438693975,-0.0055421642628754,1.1960114587924195,1
2021-04-29,"Oncologic Drugs Adcomm Backs Merck's Keytruda, Roche's Tecentriq Accelerated Approvals In Bladder Cancer",RHHBY,-0.0055421642628754,1.1960114587924195,-0.0083631911237432,0.0016754795972819,-0.0139250188489545,-0.0035277197777257,-0.0155128542483364,-0.0135691805601583,-0.7738698509859013,1
2021-06-07,Argenx Regains Global Rights from Johnson & Johnson to Blood Cancer Candidate Cusatuzumab,RHHBY,0.0344594950140635,0.7871939736346516,0.0160182851464147,0.0104046237344057,-0.0018463228130723,-0.0098262490453563,0.0062082861359455,0.0,-0.2446511201722637,2
2021-06-14,"JNJ's Imbruvica, AbbVie's Venclexta Combo Achieves Progression-Free Survival Of 78.4% Versus Gazyva-Chemo Cocktail In Leukemia Patients",RHHBY,0.0021026166817272,-0.6745878927347015,-0.0046044406693956,0.0069546947229317,0.0330937910869122,0.0,0.0344594950140635,0.0023080169315958,-0.4390243902439024,2
2021-06-14,"""FAANG"" Stocks In Focus After Congress Proposes Bills Designed To Reduce Their Influence",RHHBY,0.0021026166817272,-0.6745878927347015,-0.0046044406693956,0.0069546947229317,0.0330937910869122,0.0,0.0344594950140635,0.0023080169315958,-0.4390243902439024,2
2021-06-24,"The Daily Biotech Pulse: Lily Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO",RHHBY,0.0101885818228004,0.1087252540064942,-0.0143162431749687,-0.0143218159645707,0.0084961283984448,-0.0086334262856579,-0.0066930886470075,0.007939976321587,-0.2849315068493151,0
2021-07-21,"The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay",RHHBY,0.0085275683525514,-0.4591134581533045,-0.0096807262649549,-0.0016451825103981,0.0047520616753047,-0.0012380896961858,0.0039362181311832,-0.0426894250643256,2.662130177514793,1
2021-07-29,"The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs",RHHBY,0.0025189713924373,0.580895008605852,0.0071881590420026,0.0115483499334509,-0.0057410682326607,0.0131409388383119,-0.0426894250643256,0.0104690585742359,-0.2422427871529667,0
2021-09-14,"The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout",RHHBY,0.0095011951511687,-0.194716618635927,-0.0081387548882482,-0.0105954272982718,-0.0268098518647252,-0.0142304328141431,-0.0112562825069556,0.0023529430170079,-0.0677561732076822,2
2021-09-27,Acceleron In Advanced $11B Buyout Talks: Bloomberg,RHHBY,-0.0086937131462352,0.232484076433121,-0.0088323438991055,0.0067229869085354,0.0030454427254356,0.008777744311238,-0.0108530982374067,-0.0175400023536691,0.729328165374677,1
2021-09-30,"The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug",RHHBY,0.006418807108425,-0.4693241731906055,0.0082570587605887,-0.0175400023536691,-0.0086937131462352,-0.0088323438991055,0.0067229869085354,0.0259511310056357,-0.002860153545085,0
2021-10-01,Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates,RHHBY,0.0259511310056357,-0.002860153545085,0.006418807108425,0.0082570587605887,-0.0175400023536691,-0.0086937131462352,-0.0088323438991055,0.0173633261272121,0.389794685990338,0
2021-10-18,"The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs",RHHBY,0.0049060408498686,0.5167898627243928,0.0138859285938952,0.0006222102603854,-0.0002074165660123,-0.012287581634082,-0.021246626079856,-0.0124085088712734,-0.1513505987190198,1
2021-10-19,"The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio",RHHBY,-0.0124085088712734,-0.1513505987190198,0.0049060408498686,0.0138859285938952,0.0006222102603854,-0.0002074165660123,-0.012287581634082,-0.0162718821899191,0.6485643970467596,1
2021-10-20,AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial,RHHBY,-0.0162718821899191,0.6485643970467596,-0.0124085088712734,0.0049060408498686,0.0138859285938952,0.0006222102603854,-0.0002074165660123,0.0226130984593455,-0.3077229299363057,0
2021-10-20,"The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review",RHHBY,-0.0162718821899191,0.6485643970467596,-0.0124085088712734,0.0049060408498686,0.0138859285938952,0.0006222102603854,-0.0002074165660123,0.0226130984593455,-0.3077229299363057,0
2021-10-22,"The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs",RHHBY,-0.0020474279487975,0.4665037377803336,0.0226130984593455,-0.0162718821899191,-0.0124085088712734,0.0049060408498686,0.0138859285938952,-0.0053344842238437,-0.5262229193216351,1
2021-11-03,"This Company Wants to Revolutionize What Matters for Hospitals, Big Pharma and Health Insurers",RHHBY,0.0075894247944419,0.0193295077016006,0.0147952559389292,0.0208980782034098,-0.0086154063629451,0.0147794088354877,-0.0100969007419414,0.0112983083786941,2.344148148148148,0
2021-11-05,Will Pfizer Outgun Merck With Oral COVID-19 Pill?,RHHBY,-0.0160721833042819,-0.581003854162052,0.0112983083786941,0.0075894247944419,0.0147952559389292,0.0208980782034098,-0.0086154063629451,0.0001991959799483,-0.2877986889405793,2
2021-11-08,"The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More",RHHBY,0.0001991959799483,-0.2877986889405793,-0.0160721833042819,0.0112983083786941,0.0075894247944419,0.0147952559389292,0.0208980782034098,0.0043816006437742,-0.2805819477434679,2
2021-11-09,ALX Oncology Falls After Updated Data For Solid Tumors Candidate,RHHBY,0.0043816006437742,-0.2805819477434679,0.0001991959799483,-0.0160721833042819,0.0112983083786941,0.0075894247944419,0.0147952559389292,-0.0041641179083014,0.2701196863392487,2
2021-11-12,"The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares",RHHBY,-0.0067473681256706,-0.044214487300094,0.0033850637440238,-0.0041641179083014,0.0043816006437742,0.0001991959799483,-0.0160721833042819,-0.0067932043763508,1.3309055118110238,1
2021-12-03,"Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests",RHHBY,-0.0034329962642298,-0.0321515467500869,0.0077329757283737,0.0073801401926767,0.0093109866514977,-0.0016525752778296,0.0016553108035408,0.0077001523365822,-0.2016520021547854,0
2022-01-31,"The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News",RHHBY,0.0057958595812346,-0.2324834233372069,0.012788394358346,0.0148935975236008,-0.0031813933687721,-0.0135982601163464,-0.0268729853884593,0.0084379791598094,0.3418240114000712,0
2022-02-03,"The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation",RHHBY,-0.0340374174812867,0.0368036660461119,-0.0046938733033167,0.0084379791598094,0.0057958595812346,0.012788394358346,0.0148935975236008,-0.0087030659321608,1.7874309392265193,1
2022-02-10,Why Are Seagen Shares Sinking Today?,RHHBY,-0.0105831473016667,-0.3946276910922378,0.0240118944368727,0.0068463974587786,0.0008565871289192,-0.0087030659321608,-0.0340374174812867,-0.0201341824327502,-0.231321370309951,1
2022-03-15,"The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial",RHHBY,0.0120559180503863,0.3501180173092053,0.0185265293310601,-0.0114991659364627,-0.02105491144894,0.0358454100939493,0.0220701926627766,0.0043887258072583,-0.4840008476372113,2
2022-03-25,"The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO",RHHBY,0.0081836022822356,2.644500078235018,0.0203666056704707,0.0004073981045267,0.0032707343636892,-0.0046796131994134,0.024171715768573,-0.0079191641202587,-0.5100463678516229,1
2022-03-30,"The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict",RHHBY,-0.0017946497521972,1.7195467422096318,0.0007982851593648,-0.0079191641202587,0.0081836022822356,0.0203666056704707,0.0004073981045267,-0.0129843988056201,-0.7039583333333334,1
2022-04-01,Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates,RHHBY,0.0218579326857057,2.6968332160450386,-0.0129843988056201,-0.0017946497521972,0.0007982851593648,-0.0079191641202587,0.0081836022822356,0.0221825818154748,0.7982563009213433,0
2022-05-23,Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer,RHHBY,0.0182436931499561,0.1161933001690886,0.009081991675472,0.0099157390204558,-0.0007431400179478,0.0062313575012957,0.0093081853149199,0.0327281573640243,-0.4989845988342096,0
2022-06-06,Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients,RHHBY,-0.00770158188839,-0.043641924479473,-0.0165680153112721,0.0117337797931036,-0.0183357495174142,-0.0120762456278427,-0.0062312736967771,-0.0070337174349562,2.0763837638376383,1
2022-07-06,"10 Most Traded OTC Stocks In June: Where Do Danone, Adidas And Grayscale Bitcoin Trust Rank?",RHHBY,0.0060139066952702,-0.2760552857676503,-0.0104736739404934,0.007192464928339,-0.0023917541069359,0.0108800903901797,-0.0203695618908076,-0.0002390614713415,0.0328947368421053,2
2022-07-21,"Benzinga Before The Bell: Baidu Beats Tesla, Finland Sells $47.5M Bitcoins, Tesla's Bitcoin Sale And Other Top Financial Stories Thursday, July 21",RHHBY,-0.0052157773701219,-0.2348039739344087,-0.0137947582693623,0.0232058309311635,-0.0155440540031089,0.0248611358730823,-0.0033677496806272,0.0028599202895749,-0.4270557029177718,2
2022-08-03,"Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial",RHHBY,0.0070251979775373,-0.2194887564866423,-0.0004842386776519,-0.0040993940395364,-0.0221645647756784,-0.005393973965667,-0.0067551869774304,-0.0089006580464482,0.0169908889436098,1
2022-08-05,These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month,RHHBY,-0.0009708280106639,-0.200726392251816,-0.0089006580464482,0.0070251979775373,-0.0004842386776519,-0.0040993940395364,-0.0221645647756784,0.0048590494076086,0.1172372008482278,2
2022-08-08,Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern,RHHBY,0.0048590494076086,0.1172372008482278,-0.0009708280106639,-0.0089006580464482,0.0070251979775373,-0.0004842386776519,-0.0040993940395364,0.0045938329478594,-0.0482646420824295,2
2022-08-10,"Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial",RHHBY,0.012996348023444,0.1541310541310541,0.0045938329478594,0.0048590494076086,-0.0009708280106639,-0.0089006580464482,0.0070251979775373,-0.0249464481209209,0.1764996297210566,1
2022-10-28,15 Global Psychedelics Executives To Keep An Eye On In 2022,RHHBY,0.0136419311832629,-0.0606866537717601,-0.0165309309712355,0.0009592822583919,0.0253258153079813,-0.0022080885401865,0.0174737545062571,-0.0064888512624383,0.96010296010296,1
2022-11-16,"Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says",RHHBY,-0.0087040340501306,-0.4354595680562532,0.0021807058151355,-0.0457802919569815,0.0169292659956814,0.028288158490441,0.0127325956327533,-0.0200000212288841,-0.5047221461812209,1
2022-11-28,This Congressman Just Purchased 2 Stocks Which Consistently Increase Dividends,RHHBY,0.0007305554177159,1.7547806524184475,0.0108321761681799,0.0190667279398992,-0.0012528093540983,-0.0059776957768284,-0.0007465556725528,-0.0104647733527877,-0.5092690894242549,1
2022-12-02,"Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors",RHHBY,-0.001458365889721,-0.0640818524501884,0.0053763809921225,0.0063943837389197,-0.0104647733527877,0.0007305554177159,0.0108321761681799,-0.0063291041714418,-0.2626582278481012,1
2022-12-12,"Broadcom-Vmware Deal Draws European Regulatory Attention, Rivian Pauses Mercedes-Partnered EV Van Plans For Europe, Credit Suisse Issued Loan On Suspicious Bills: Top Stories Monday, Dec. 12",RHHBY,-0.0004935843314808,-0.0575593952483801,0.0009883398383561,0.0130162503086055,-0.0079463799142583,-0.0134737813758087,-0.0063291041714418,0.0167941607516894,0.0605018906840839,0
2023-01-06,"Twitter Hackers Stole More Than 200M Emails, Delta Air Lines To Offer Free Wi-Fi, Bed Bath & Beyond's Bankruptcy Coming Sooner Than Expected: Top Stories Today",RHHBY,0.0164355798482689,-0.3071669327656555,-0.0238155100338968,0.015788093465207,0.0030650903479616,-0.0111138925405559,0.0107225924996696,-0.0050530186118652,1.4286262962488796,1
2023-02-23,"Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge",RHHBY,-0.0065911428291295,0.011914774320157,0.0010557421629338,0.0002639268683399,0.0180059670795238,-0.0106354934835314,-0.0060781988749869,,,2
